# Chlorofluorocarbon Propellants in Self-Pressurized Containers; Addition to List of Essential Uses
> **Food and Drug Administration** · Final rule. · Published 1996-04-09 · 61 FR 15699
## Document
- **Document number:** 96-8826
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 61 FR 15699
- **CFR reference:** 21 CFR 2
- **Publication date:** 1996-04-09
- **HHS docket:** Docket No. 92P-0403
## Abstract

The Food and Drug Administration (FDA) has granted the petition of Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI), to add metered-dose albuterol sulfate and ipratropium bromide in combination for oral inhalation to the list of products containing a chlorofluorocarbon (CFC) propellant for an essential use. Essential use products are exempt from FDA's ban on the use of CFC propellants in FDA-regulated products and the Environmental Protection Agency's (EPA's) ban on the use of CFC's in pressurized dispensers. This document amends FDA's regulations governing use of CFC's to include metered-dose albuterol sulfate and ipratropium bromide in combination for oral inhalation as an essential use.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/1996/04/09/96-8826/chlorofluorocarbon-propellants-in-self-pressurized-containers-addition-to-list-of-essential-uses)
---
*AI Analytics · CC0 1.0*